Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 110.61M | 37.8M | 23.38M | 46.34M | 53.84M | 39.55M | 71.69M | -42.52M | 187.66M | 298.17M | 418.54M | 87.29M | 94.37M | 89.96M | 121.42M | 204.95M | 114.01M |
Short-Term Investments | 20.24M | 50.55M | 67.98M | 49.73M | 46.14M | 62.88M | 62.32M | 209.97M | 53.6M | 29.31M | 68.29M | 45.56M | 53.15M | 83.51M | 94.79M | 60M | 95.96M |
Long-Term Investments | n/a | n/a | n/a | n/a | 836K | 836K | 836K | 836K | 18.78M | 836K | 836K | 148.25M | 94.11M | 67.54M | 45.09M | 35.82M | 19.44M |
Other Long-Term Assets | 158.86M | 157.32M | 202.5M | 202.76M | 202.1M | 202.27M | 204.2M | 205.78M | 207.13M | 201.1M | 199.07M | 4.14M | 4.03M | 4.07M | 4.13M | 2.16M | 3.14M |
Receivables | 15.35M | 68.44M | 16.84M | 14.3M | 14.66M | 17.47M | 17.06M | 15.8M | 12.27M | 16.79M | 14.11M | 12.49M | 47.84M | 57.6M | 57.77M | 39.96M | 54.27M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 979K | 1.52M | 1.51M | -68.29M | n/a | n/a | 10.24M | 13.24M | 15.91M | 18.79M |
Other Current Assets | 4.06M | 4.2M | 7.68M | 6.28M | 7.57M | 11.6M | 9M | 7.78M | 6.28M | 7.68M | 8.13M | 7.08M | 4.54M | 8.56M | 9.94M | 12.35M | 10.04M |
Total Current Assets | 150.26M | 161.07M | 116.48M | 119.31M | 124.29M | 133.54M | 161.69M | 192M | 261.34M | 353.46M | 511.72M | 154.73M | 204.64M | 249.87M | 297.17M | 333.18M | 293.07M |
Property-Plant & Equipment | 34.46M | 35.77M | 37.12M | 39.96M | 44.08M | 45.35M | 46.86M | 48.01M | 51.31M | 52M | 51.88M | 53.64M | 52.59M | 53.35M | 56.72M | 58.09M | 59.46M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 193.32M | 193.09M | 239.63M | 242.72M | 247.01M | 248.46M | 251.9M | 254.63M | 277.21M | 253.94M | 251.78M | 206.03M | 150.72M | 124.95M | 105.94M | 96.07M | 82.04M |
Total Assets | 343.58M | 354.16M | 356.11M | 362.03M | 371.31M | 382M | 413.59M | 446.63M | 538.55M | 607.4M | 763.5M | 360.76M | 355.36M | 374.82M | 403.11M | 429.25M | 375.11M |
Account Payables | 2.41M | 2.24M | 1.45M | 1.67M | 1.69M | 1.52M | 2.37M | 1.57M | 2.66M | 1.55M | 5.34M | 3.07M | 1.51M | 3.1M | 8.9M | 10.7M | 6.83M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -5.45M | 24K | 24K | 24K | 24K | 24K | 24K | 98K | 98K | 2.9M | 5.69M | 7.66M |
Short-Term Debt | n/a | n/a | n/a | 4.22M | n/a | 3.92M | 9.71M | 9.16M | 7.43M | n/a | 692K | 2.62M | 9.01M | 16.94M | 12.53M | 6.94M | 11.66M |
Other Current Liabilities | n/a | n/a | 6.49M | 7.06M | 11.44M | 8.95M | -6.06M | -1.48M | 7.21M | 10.07M | 127.83M | 34.64M | 39.93M | 50.3M | 64.2M | 56.24M | 86.99M |
Total Current Liabilities | 31.5M | 32.09M | 23.43M | 22.95M | 21.66M | 24.77M | 25.37M | 24.55M | 26.18M | 28.71M | 142.13M | 32.62M | 44.2M | 58.59M | 66.08M | 67.13M | 86.49M |
Long-Term Debt | n/a | n/a | n/a | 42.44M | 43.84M | 45.24M | 41.12M | 42.52M | 43.76M | n/a | 51.38M | 624.7M | 612.46M | 599.39M | 603.34M | 602.57M | 602.41M |
Other Long-Term Liabilities | 108.75M | 107.42M | 106.23M | 60.51M | 57.1M | 53.77M | 59.68M | 56.7M | 54.09M | 91.29M | 37.83M | 2.4M | 2.43M | 2.42M | 2.61M | 1.83M | 2.06M |
Total Long-Term Liabilities | 146.1M | 146.53M | 147.02M | 145.39M | 144.78M | 144.24M | 142.09M | 141.92M | 141.81M | 136.88M | 140.79M | 677.95M | 662.61M | 654.8M | 660.62M | 662.5M | 661.83M |
Total Liabilities | 177.6M | 178.62M | 170.45M | 168.34M | 166.44M | 169M | 167.46M | 166.47M | 167.99M | 165.6M | 282.92M | 710.57M | 706.81M | 713.39M | 726.7M | 729.63M | 748.33M |
Total Debt | 48.16M | 49.82M | 44.98M | 46.66M | 47.9M | 49.16M | 50.83M | 51.68M | 43.76M | 74.12M | 52.07M | 675.34M | 672.95M | 652.08M | 657.69M | 660.34M | 659.44M |
Common Stock | 1K | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -979.1M | -965.52M | -950M | -937.3M | -920.77M | -909.1M | -900.59M | -891.64M | -876M | -853.91M | -843.55M | -1.76B | -1.75B | -1.73B | -1.69B | -1.66B | -1.61B |
Comprehensive Income | n/a | 7K | 50K | -22K | -41K | -65K | -225K | -286K | 51K | -15K | -121K | -45K | -28K | -0.00 | 14K | 8K | 17K |
Shareholders Equity | 165.98M | 175.54M | 185.65M | 193.69M | 204.87M | 213M | 246.13M | 280.16M | 370.56M | 441.8M | 480.58M | -349.81M | -351.45M | -338.57M | -323.59M | -300.37M | -373.22M |
Total Investments | 20.24M | 50.55M | 67.98M | 49.73M | 46.14M | 62.88M | 62.32M | 61.85M | 72.37M | 29.31M | 68.29M | 193.81M | 147.26M | 151.04M | 139.88M | 95.83M | 115.4M |